Home Phototherapy: Clinical Insights, Coverage, and Technology for Safer Prescribing

Guided Mode is Phothera’s new built-in treatment protocol system that standardizes narrowband UVB dosing according to AAD clinical guidelines. It ensures the same precision and safety patients receive in-office — now at home.

Beginning Q1, all new Phothera home phototherapy devices will include Guided Mode by default.
The transition is driven by improvements in patient safety, adherence, and efficacy — ensuring every patient receives a medically appropriate, evidence-based regimen automatically.

Automatically sets and limits dose escalation per protocol

Built-in lockout prevents overexposure

Monitors total cumulative dose for safety thresholds

Yes. Phothera’s Guided Mode technology is FDA-cleared.
No hardware change — the update is software-driven to ensure dosing precision.

Patients will see a new “Guided Mode” treatment screen that automatically sets exposure times and treatment frequency.
They’ll also receive simplified instructions emphasizing adherence and built-in safety checks. No manual calibration is needed.

Yes — coverage is unchanged and stronger than ever:

98% of Kaiser Permanente patients are fully covered

Phothera handles all claims, prior authorizations, and appeals

No upfront payment — devices ship once Rx is received

Phothera Cares offers $0 copay eligibility and payment plans for others

Most prescriptions are processed and shipped within 3 business days of Rx receipt.

Guided Mode covers all existing clinical indications:
Psoriasis, Vitiligo, Atopic Dermatitis, CTCL/Mycosis Fungoides, and Chronic Pruritus.

No — prescribing workflow remains identical. Skin type is required on the prescription.
Providers continue using the same Rx form. Guided Mode simply ensures each patient’s treatment plan follows evidence-based dosing automatically.

Mike Franks

Email: [email protected]